Public Company News

The U.S. FDA Granted Fast Track Designation to Dizal's Birelentinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

* Birelentinib (DZD8586) received Fast Track Designation from the U.S. FDA for relapsed/refractory CLL/SLL * Supporting data from a pooled analysis of phase I/II studies of birelentinib showed an objective response rate of 84.2% in heavily pretreated CLL/SLL patients SHANGHAI, Aug. 6, 2025 /P...

2025-08-06 19:02 1595

Newborn Town Issues Positive Profit Alert for First-Half 2025: Adjusted Operating Profit Surpasses RMB 600 Million, while the Profit Attributable to the Company's Equity Shareholders Increases over 108% YoY

HONG KONG, Aug. 6, 2025 /PRNewswire/ -- On August 6th, Newborn Town (9911.HK) released a positive profit alert for the first half of 2025. The Group achieved rapid revenue expansion alongside a substantial increase in profit, driven by the dual-engine growth of its social networking and innovativ...

2025-08-06 19:00 3122

GIBO Click Powers Advanced Audience Intelligence and Monetization Logic in Successful Trial with CoolShort

HONG KONG, Aug. 6, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a leader in AI-driven content monetization infrastructure, today announced the successful trial ofGIBO Click on CoolShort

2025-08-06 18:30 1667

GIBO Holdings Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request

HONG KONG, Aug. 6, 2025 /PRNewswire/ -- GIBO Holdings Limited ("GIBO" or the "Company"), a unique and integrated AIGC animation streaming platform, today announced it received a letter from The Nasdaq Stock Market LLC ("Nasdaq") on August 4, 2025, notifying that the Company is not in compliance wi...

2025-08-06 18:00 1584

ATRenew to Report Second Quarter 2025 Financial Results on August 20, 2025

SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced that it plans to release its unaudited financial results for the second quarter of ...

2025-08-06 16:00 1315

Despite 48% Interest, Over 90% of Global Consumers Have Reservations About AI For BF/CM

New Sinch survey reveals trust, not just technology, will influence which brands break through this holiday season STOCKHOLM, Aug. 6, 2025 /PRNewswire/ -- Sinch AB (publ) (XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, today released n...

2025-08-06 15:56 1189

ADNOC Gas Announces Record Second Quarter Performance, Demonstrating Resilience in Lower Price Environment

Highest-ever quarterly net income of $1.385 billion, up 16% YoY, reflects the Company's strong performance Board approves interim dividend of $1.792 billion, a 5% increase YoY, to be distributed in September ADNOC Gas on track for entry into FTSE Index in September 2025 ABU DHABI, UAE, Aug. 6, ...

2025-08-06 15:16 2811

Everest Medicines Announces Full Approval of NEFECON® in Taiwan

SHANGHAI, Aug. 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the Taiwan Food and Drug Administrati...

2025-08-06 13:09 1623

Silicon Motion Showcases MonTitan™ SM8366 in Core to Edge AI Server Applications at FMS 2025

Company Also Demonstrates Full Spectrum of AI Storage Solutions for PCs, Gaming, Edge, Robotics, and Automotive TAIPEI and MILPITAS, Calif., Aug. 6, 2025 /PRNewswire/ -- Silicon Motion Technology Corporation (NasdaqGS: SIMO) ("Silicon Motion"), a global leader in designing and marketing NAND fla...

2025-08-06 09:00 1700

WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year

SHANGHAI, Aug. 5, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced its inclusion in the FTSE4Good Index Series for the third consecutive year....

2025-08-06 08:00 1718

Calm Stores, Clear Sites: New Research Highlights How Seniors are Redefining Retail Expectations

SYDNEY, Aug. 6, 2025 /PRNewswire/ -- While many Australians are adjusting their spending in response to rising cost-of-living, new research from Manhattan Associates Inc.  (NASDAQ: MANH) reveals that older Australians continue to play a significant role in discretionar...

2025-08-06 08:00 1494

BeLive Technology Joins Forces with Insight Lab to Unlock Real-Time Viewer Insights Across Asia

SINGAPORE, Aug. 5, 2025 /PRNewswire/ -- BeLive Holdings (NASDAQ: BLIV), a global interactive live streaming & video solutions provider, has entered a strategic partnership with one ofJapan's leading data strategy firms INSIGHT LAB Inc., to bringreal-time analytics, AI, and personalized viewer eng...

2025-08-05 21:15 3400

Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics

* Dr. Jong-Yoon Chun, Chairman and CEO of Seegene, highlights progress toward fully automated and data-driven molecular testing * Introduction of CURECA™, the first fully unattended PCR automation system, and STAgora™, a real-time global data analytics platform * Technologies designed to sca...

2025-08-05 21:07 2210

BON Announces Reciept of Nasdaq Compliance Letter

XI'AN, China, Aug. 5, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC. As ...

2025-08-05 21:00 3103

TECHTRONIC INDUSTRIES DELIVERS STRONG FIRST HALF PERFORMANCE

GROWING SALES TO US$7.8 BILLION, NET PROFIT INCREASED TO US$628 MILLION HONG KONG, Aug. 5, 2025 /PRNewswire/ -- Global cordless power tool, outdoor power equipment and floorcare & cleaning company Techtronic Industries Co. Ltd. ("TTI" or the "Group") (stock code: HK: 0669, ADR symbol: TTNDY) is p...

2025-08-05 20:42 3456

Recon Awarded Mega $5.85 Million Contract to Provide Upgrades Service for Large Mid-Asia Gas Field

BEIJING, Aug. 5, 2025 /PRNewswire/ -- Recon Technology Ltd. ("Recon" or "the Company"), aChina-based provider of oilfield and low-carbon energy services, announced today that one of its domestic affiliated entities has been awarded major contracts to upgrade and retrofit related automation system...

2025-08-05 20:30 2886

iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application

•  Successful validation of payloaded anti-colibactin toxin phage using IMPA™ technology  •  Demonstrated 'Dual-target Therapeutic Strategy' by bacterial eradication and toxin neutralization  •  Filed the US patent application for the candidate substance and preclinical studies including PoC unde...

2025-08-05 20:00 1518

Court Sides with Cardiovalve in Edwards patent spat

HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary Cardiovalve Ltd. ("Cardiovalve") against Edwards Lifesciences Corporation and Edwards Lifesciences LLC. ...

2025-08-05 20:00 1647

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight

-          13-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two oral formulations of ASC30, a once-daily tablet, in 125 participants with obesity or overweight. -         All 125 participants enrolled in just over one month; topline data expected in the fourth ...

2025-08-05 18:50 1503

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collab...

2025-08-05 18:40 1359